BioMaxima S.A. (WSE:BMX)

Poland · Delayed Price · Currency is PLN

9.58

-0.10 (-1.03%)

Jun 16, 2026, 1:04 PM CET

-33.47% (1Y)

Market Cap	40.59M -33.9%
Revenue (ttm)	60.90M +15.2%
Net Income	105.00K -80.4%
EPS	0.03 -80.4%
Shares Out	4.19M
PE Ratio	386.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,013
Open	9.58
Previous Close	9.68
Day's Range	9.47 - 9.67
52-Week Range	9.30 - 14.75
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About BioMaxima

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in v... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1997

Employees 135

Stock Exchange Warsaw Stock Exchange

Ticker Symbol BMX

Full Company Profile

Financial Performance

In 2025, BioMaxima's revenue was 60.90 million, an increase of 15.24% compared to the previous year's 52.85 million. Earnings were 105,000, a decrease of -80.37%.

Financial Statements